Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.
J. Infect. Dis., Dec;204(12):1918-26 (2011)
Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.
J. Immunol., May;188(10):5177-88 (2012)
Analysis of HIV diversity using a high-resolution melting assay.
AIDS Res. Hum. Retroviruses., Aug;26(8):913-8 (2010)
Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms.
AIDS Res. Hum. Retroviruses., Oct;27(10):1135-7 (2011)
A 61 year-old female with a prior history of tuberculosis presenting with hemoptysis.
Clin. Infect. Dis., Apr;52(7):910, 957-9 (2011)
Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
J. Virol., May;84(10):5067-77 (2010)
Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.
J. Virol., Jul;84(14):7018-28 (2010)
Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors.
Retrovirology., 7:94 (2010)
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral
J. Virol., Oct;83(19):9731-42 (2009)
Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
Gastroenterology., Jan;138(1):315-24 (2010)
Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.
J. Acquir. Immune Defic. Syndr., Oct;49(2):136-41 (2008)
HIV-1 evolution following transmission to an HLA-B*5801-positive patient.
J. Infect. Dis., Dec;200(12):1820-4 (2009)
Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.
Hepatology., Jul;42(1):104-12 (2005)
Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.
J. Virol., May;80(10):4758-70 (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
J. Virol., Jul;80(13):6441-57 (2006)
A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
J. Virol. Methods., Sep;136(1-2):238-47 (2006)
Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution.
J. Virol., Jun;81(12):6513-22 (2007)
Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
AIDS Res. Hum. Retroviruses., Mar;23(3):381-90 (2007)
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
J. Infect. Dis., May;195(10):1402-10 (2007)
CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load.
Clin. Infect. Dis., Apr;46(8):e78-82 (2008)
Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples.
Clin. Infect. Dis., Apr;46(8):1227-36 (2008)
Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor.
J. Virol., Aug;82(15):7395-410 (2008)
Maternal neutralizing antibody and transmission of hepatitis C virus to infants.
J. Infect. Dis., Dec;198(11):1651-5 (2008)
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
J. Immunol., Dec;181(12):8215-25 (2008)
Dynamics of SEN virus infection among injection drug users.
J. Infect. Dis., Nov;184(10):1315-9 (2001)
Needlestick transmission of hepatitis C.
JAMA., May;287(18):2406-13 (2002)
Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
J. Virol., Sep;76(18):9481-92 (2002)
Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.
J. Virol., Jan;78(2):968-79 (2004)
G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.
J. Virol., Feb;79(3):1975-80 (2005)
A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
J. Virol., Apr;79(8):5185-202 (2005)
Cellular immune selection with hepatitis C virus persistence in humans.
J. Exp. Med., Jun;201(11):1741-52 (2005)
Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.
J. Exp. Med., Jun;201(11):1753-9 (2005)
Presence in India of HIV type 1 similar to North American strains.
AIDS Res. Hum. Retroviruses., Aug;10(8):1039-41 (1994)
Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.
J. Infect. Dis., Apr;171(4):797-804 (1995)
Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression.
J. Virol., Dec;69(12):7548-58 (1995)
Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.
AIDS Res. Hum. Retroviruses., Jan;14(1):3-13 (1998)
Determinants of the quantity of hepatitis C virus RNA.
J. Infect. Dis., Mar;181(3):844-51 (2000)
Genetic epidemiology of hepatitis C virus throughout egypt.
J. Infect. Dis., Sep;182(3):698-707 (2000)
Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.
Hepatology., Jun;55(6):1684-91 (2012)
Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.
Hepatology., Aug;56(2):544-54 (2012)
Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India.
Indian J. Med. Res., Dec;132:706-14 (2010)
Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1.
J. Infect. Dis., May;199(9):1301-9 (2009)
Molecular epidemiology of HIV-1 subtypes in southern China.
J. Acquir. Immune Defic. Syndr., Mar;38(3):356-62 (2005)
Report from ICAAC 2000: HIV & viral co-infections.
Hopkins HIV Rep., Nov;12(5):5 (2000)
Determinants of viral clearance and persistence during acute hepatitis C virus infection.
J. Exp. Med., Nov;194(10):1395-406 (2001)
Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies.
J. Virol., Apr;75(7):3259-67 (2001)
Evolution of human immunodeficiency virus type 1 in relation to disease progression in children.
J. Hum. Virol., 1(3):224-39 (1998)
PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease.
J. Clin. Microbiol., Mar;37(3):686-9 (1999)
Sex and the genetic diversity of HIV-1.
Nat. Med., Jan;6(1):23-5 (2000)
Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs.
J. Clin. Microbiol., Oct;36(10):2982-9 (1998)
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Am. J. Med., Jul;101(1):68-76 (1996)
Acute appendicitis. A clinical appraisal of 500 cases.
J Indian Med Assoc., Jun;52(11):509-13 (1969)